These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 6095462

  • 1. Malaria antibody levels in patients with nasopharyngeal carcinoma.
    Yadav M, Prasad U.
    Southeast Asian J Trop Med Public Health; 1984 Jun; 15(2):234-7. PubMed ID: 6095462
    [Abstract] [Full Text] [Related]

  • 2. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H, Nowak R, Donner A, Kunkel M, Gärtner L, Scholtz HJ.
    Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
    [Abstract] [Full Text] [Related]

  • 3. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
    Dölken G, Bitzer M, Bross KJ, Brugger W, Boldt C, Hirsch FW, Weitzmann U, Löhr GW.
    Dtsch Med Wochenschr; 1984 Nov 30; 109(48):1837-43. PubMed ID: 6094138
    [Abstract] [Full Text] [Related]

  • 4. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
    Karray H, Ayadi W, Fki L, Hammami A, Daoud J, Drira MM, Frikha M, Jlidi R, Middeldorp JM.
    J Med Virol; 2005 Apr 30; 75(4):593-602. PubMed ID: 15714486
    [Abstract] [Full Text] [Related]

  • 5. Serological and immunohistological assessment of Epstein-Barr virus infection in Sicilian patients with suspected nasopharyngeal carcinoma.
    Ammatuna P, de Thè G, Speciale R, Sammartano F, Arista S, Zerillo G.
    Microbiologica; 1988 Apr 30; 11(2):89-94. PubMed ID: 2841559
    [Abstract] [Full Text] [Related]

  • 6. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
    Dardari R, Menezes J, Drouet E, Joab I, Benider A, Bakkali H, Kanouni L, Jouhadi H, Benjaafar N, El Gueddari B, Hassar M, Khyatti M.
    J Clin Virol; 2008 Feb 30; 41(2):96-103. PubMed ID: 18024156
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. IgG and IgA antibodies to Epstein-Barr virus in nasopharyngeal carcinoma patients.
    Gong SH, Lynn TC, Yang CS.
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1978 Mar 30; 11(1):8-15. PubMed ID: 211015
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and of EBV serology.
    Faggioni A, Corradini C, Venanzoni M, Cardi G, Bevere F, Barile G, Zompetta C, Frati L.
    J Exp Pathol; 1987 Mar 30; 3(4):471-7. PubMed ID: 2842480
    [Abstract] [Full Text] [Related]

  • 13. EBV-specific humoral antibodies in nasopharyngeal carcinoma patients in Cuba.
    Ruiz R, Gurtsevich V, Le Riverend E.
    Neoplasma; 1979 Mar 30; 26(2):125-31. PubMed ID: 224330
    [Abstract] [Full Text] [Related]

  • 14. Significance of plasma IgA and IgG antibodies to Epstein-Barr virus early and viral capsid antigens in Thai nasopharyngeal carcinoma.
    Tiwawech D, Srivatanakul P, Karaluk A, Ishida T.
    Asian Pac J Cancer Prev; 2003 Mar 30; 4(2):113-8. PubMed ID: 12875623
    [Abstract] [Full Text] [Related]

  • 15. Humoral immune response in Epstein-Barr virus infections. I. Elevated serum concentration of the IgG1 subclass in infectious mononucleosis and nasopharyngeal carcinoma.
    Kaschka WP, Hilgers R, Skvaril F.
    Clin Exp Immunol; 1982 Jul 30; 49(1):149-56. PubMed ID: 6290114
    [Abstract] [Full Text] [Related]

  • 16. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX.
    Cancer; 2004 Mar 15; 100(6):1162-70. PubMed ID: 15022282
    [Abstract] [Full Text] [Related]

  • 17. Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients.
    Hadar T, Rahima M, Kahan E, Sidi J, Rakowsky E, Sarov B, Sarov I.
    J Med Virol; 1986 Dec 15; 20(4):329-39. PubMed ID: 3025351
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.
    Twu CW, Wang WY, Liang WM, Jan JS, Jiang RS, Chao J, Jin YT, Lin JC.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):130-7. PubMed ID: 16979842
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of IgA specific antibodies to Epstein-Barr virus capsid and early antigens in nasopharyngeal carcinoma.
    Puthavathana P, Kositanont U, Chongkolwatana C, Metheetrairut C, Chantarakul N, Nuntarakchaikul S, Wasi C.
    Asian Pac J Allergy Immunol; 1993 Jun 01; 11(1):39-43. PubMed ID: 8216557
    [Abstract] [Full Text] [Related]

  • 20. Epstein Barr virus (EBV) antibodies in the diagnosis of NPC--comparison between IFA and two commercial ELISA kits.
    Chan SH, Soo MY, Gan YY, Fones-Tan A, Sim PS, Kaur A, Chew CT.
    Singapore Med J; 1998 Jun 01; 39(6):263-5. PubMed ID: 9803815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.